• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要体外膜肺氧合支持的自身免疫性疾病患者的暴发性心肌炎

Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support.

作者信息

Depta Filip, Olejárová Ingrid, Rybár Dušan, Murín Pavol, Švajdler Marián, Grendel Tomáš

机构信息

Department of Critical Care, East Slovak Institute for Cardiovascular Diseases, Košice, Slovakia.

Department of Critical Care, National Institute of Cardiovascular Diseases, Bratislava, Slovakia.

出版信息

Tex Heart Inst J. 2024 Sep 16;51(2). doi: 10.14503/THIJ-24-8431.

DOI:10.14503/THIJ-24-8431
PMID:39279267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403156/
Abstract

Myocarditis is a potentially life-threatening inflammatory disease of the myocardium, often resulting from infectious and immune-mediated responses. Clinical presentation in severe cases often results in a devastating illness requiring extracorporeal membrane oxygenation support as a result of cardiogenic shock. Although endomyocardial biopsy is still considered the gold standard for diagnosis, it often reveals nonspecific lymphocytic infiltration. Because the precise cause is usually unknown, the initial treatment typically involves immunosuppression and frequent assessment of myocardial contractility. This report presents 3 rare cases of autoimmune diseases (polymyositis, immunoglobulin G4-related disease, and systemic lupus erythematosus) that require extracorporeal membrane oxygenation support as a result of fulminant myocarditis, including their follow-up periods.

摘要

心肌炎是一种潜在威胁生命的心肌炎症性疾病,通常由感染和免疫介导反应引起。严重病例的临床表现常导致一种毁灭性疾病,因心源性休克而需要体外膜肺氧合支持。尽管心内膜心肌活检仍被认为是诊断的金标准,但它通常显示非特异性淋巴细胞浸润。由于确切病因通常不明,初始治疗通常包括免疫抑制和频繁评估心肌收缩力。本报告介绍了3例罕见的自身免疫性疾病(多发性肌炎、免疫球蛋白G4相关疾病和系统性红斑狼疮),这些疾病因暴发性心肌炎而需要体外膜肺氧合支持,包括它们的随访期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/516b64e40ec6/i1526-6702-51-2-e248431-f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/dc6db170798c/i1526-6702-51-2-e248431-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/b8fc7c330a6e/i1526-6702-51-2-e248431-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/1991fa2a693f/i1526-6702-51-2-e248431-f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/92e7cf8364fa/i1526-6702-51-2-e248431-f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/1622f82de9b8/i1526-6702-51-2-e248431-f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/516b64e40ec6/i1526-6702-51-2-e248431-f06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/dc6db170798c/i1526-6702-51-2-e248431-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/b8fc7c330a6e/i1526-6702-51-2-e248431-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/1991fa2a693f/i1526-6702-51-2-e248431-f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/92e7cf8364fa/i1526-6702-51-2-e248431-f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/1622f82de9b8/i1526-6702-51-2-e248431-f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da5/11403156/516b64e40ec6/i1526-6702-51-2-e248431-f06.jpg

相似文献

1
Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support.需要体外膜肺氧合支持的自身免疫性疾病患者的暴发性心肌炎
Tex Heart Inst J. 2024 Sep 16;51(2). doi: 10.14503/THIJ-24-8431.
2
Prognostic Factors Associated With Early Recovery From Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients With Fulminant Myocarditis.暴发性心肌炎患者静脉-动脉体外膜肺氧合支持早期恢复的相关预后因素
J Am Heart Assoc. 2025 Jun 17;14(12):e039673. doi: 10.1161/JAHA.124.039673. Epub 2025 Jun 16.
3
Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort.机械循环支持下暴发性巨细胞心肌炎:法国多中心队列的管理和结局。
Int J Cardiol. 2018 Feb 15;253:105-112. doi: 10.1016/j.ijcard.2017.10.053.
4
Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis.经皮体外膜肺氧合治疗暴发性心肌炎所致心原性休克。
Ann Thorac Surg. 2010 Feb;89(2):614-6. doi: 10.1016/j.athoracsur.2009.07.047.
5
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors.采用体外膜肺氧合治疗暴发性心肌炎患者的短期死亡率及危险因素的系统评价和荟萃分析。
Heart Fail Rev. 2023 Mar;28(2):347-357. doi: 10.1007/s10741-022-10277-z. Epub 2022 Oct 7.
6
Total thyroidectomy performed under general anesthesia with venovenous extracorporeal membrane oxygenation during a thyroid storm: a case report.在甲状腺危象期间,在静脉-静脉体外膜肺氧合辅助下全身麻醉下行甲状腺全切除术:一例报告
J Cardiothorac Surg. 2025 Jun 25;20(1):273. doi: 10.1186/s13019-025-03491-x.
7
Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.左西孟旦对静脉-动脉体外膜肺氧合结局的影响:一项系统评价和荟萃分析
Clin Res Cardiol. 2024 Apr;113(4):509-521. doi: 10.1007/s00392-023-02208-1. Epub 2023 May 22.
8
Extracorporeal membrane oxygenation for critically ill adults.危重症成人的体外膜肺氧合
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010381. doi: 10.1002/14651858.CD010381.pub2.
9
Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.在暴发性嗜酸性心肌炎合并心源性休克的情况下短期使用“ECMELLA”。
BMC Cardiovasc Disord. 2020 Dec 10;20(1):519. doi: 10.1186/s12872-020-01808-3.
10
Venoarterial Extracorporeal Membrane Oxygenation Therapy in Patients with Sickle Cell Disease: Case Series and Review for Intensive Care Physicians.镰状细胞病患者的静脉-动脉体外膜肺氧合治疗:病例系列及对重症监护医师的综述
J Intensive Care Med. 2025 Sep;40(9):929-936. doi: 10.1177/08850666241260605. Epub 2024 Aug 14.

本文引用的文献

1
Myocarditis.心肌炎
N Engl J Med. 2022 Oct 20;387(16):1488-1500. doi: 10.1056/NEJMra2114478.
2
Systemic lupus erythematosus myocarditis after COVID-19 vaccination.新冠病毒疫苗接种后发生的系统性红斑狼疮性心肌炎
Reumatol Clin. 2023 Feb;19(2):114-116. doi: 10.1016/j.reuma.2022.06.003. Epub 2022 Jul 28.
3
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies.
在免疫抑制治疗引入之前,心肌炎复发、死亡或需要心脏移植的预测因素:女性、暴发性发作、射血分数降低和血清自身抗体与预后不良相关。
Eur J Heart Fail. 2022 Jun;24(6):1033-1044. doi: 10.1002/ejhf.2496. Epub 2022 Apr 19.
4
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy.治疗性血浆置换治疗难治性坏死性自身免疫性肌病。
J Clin Apher. 2022 Jun;37(3):253-262. doi: 10.1002/jca.21968. Epub 2022 Feb 4.
5
Heart transplantation in systemic lupus erythematosus: A case report and meta-analysis.系统性红斑狼疮患者的心脏移植:一例病例报告及荟萃分析
Heart Lung. 2022 Mar-Apr;52:174-181. doi: 10.1016/j.hrtlng.2022.01.003. Epub 2022 Jan 20.
6
Cardiogenic shock as the initial manifestation of systemic lupus erythematosus.以心原性休克为首发表现的系统性红斑狼疮
ESC Heart Fail. 2020 Aug;7(4):1992-1996. doi: 10.1002/ehf2.12806. Epub 2020 Jun 9.
7
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.暴发性心肌炎的识别和初步处理:美国心脏协会的科学声明。
Circulation. 2020 Feb 11;141(6):e69-e92. doi: 10.1161/CIR.0000000000000745. Epub 2020 Jan 6.
8
A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study.基于生命支持的综合治疗方案显著降低暴发性心肌炎患者的院内死亡率:一项多中心研究。
Sci China Life Sci. 2019 Mar;62(3):369-380. doi: 10.1007/s11427-018-9501-9. Epub 2019 Feb 28.
9
Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.淋巴细胞性心肌炎的免疫调节治疗:系统评价和荟萃分析。
Heart Fail Rev. 2018 Jul;23(4):573-581. doi: 10.1007/s10741-018-9709-9.
10
Cardiac Autoimmunity: Myocarditis.心脏自身免疫:心肌炎
Adv Exp Med Biol. 2017;1003:187-221. doi: 10.1007/978-3-319-57613-8_10.